This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Evodia rutaecarpa is a traditional Chinese medicinal herb used for various ailments, containing bioactive indole alkaloids with cardiovascular, gastrointestinal, and neuroprotective properties [PMID:30616017, PMID:37741256].
Background
Evodia rutaecarpa (also known as Wu Zhu Yu) is a tree native to China and Korea, from which the near-ripe or dry unripened fruit is used as a medicinal herb [PMID:30616017, PMID:37741256, PMID:27771931, PMID:35463684].
Traditional uses
In China, it is clinically used to treat headache, abdominal pain, abdominal distension, vomiting, diarrhea, postpartum hemorrhage, dysentery, and amenorrhea [PMID:30616017, PMID:37741256, PMID:35379148].
Active compounds
The major bioactive compounds are indole alkaloids, specifically evodiamine (EVO), rutaecarpine (RUT), and dehydroevodiamine (DHE) [PMID:37741256, PMID:19471205]. Other identified components include evodol (a furanoid) [PMID:37092795].
Mechanism of action
Rutaecarpine targets TRPV1, CGRP, AMPK, ABCA1, and β1-AR [PMID:30616017], and protects endothelial cells via TRPV1- and AhR-mediated Nrf2 activation [PMID:40427497]. Evodiamine may induce PANoptosis in microglia to reduce neuroinflammation [PMID:41242627], induce ferroptosis in prostate cancer cells by inhibiting TRIM26-mediated stabilization of GPX4 [PMID:40420092], and regulate the C/EBP-β-COX2 axis to attenuate neuroinflammation [PMID:39798734].
Clinical evidence
Evidence BChemotherapy-induced nausea and vomiting (CINV)
Hezhong granules (containing Evodia rutaecarpa) are used to prevent CINV in patients with advanced colorectal cancer [PMID:38341113]
Evidence ADigestive system diseases
Evodiamine has a positive therapeutic effect on various digestive system diseases, including colorectal cancer, gastric ulcers, liver cancer, liver fibrosis, and ulcerative colitis [PMID:39018943]
Evidence CAlzheimer's Disease
Bioactive alkaloid components can ameliorate cognitive impairments and neurological damage through anti-inflammatory, antioxidant, and anti-acetylcholinesterase activities [PMID:38173117]
Evidence DIschemic Stroke
Rutaecarpine showed therapeutic effects against ischemic stroke, involving the MAPK pathway and targets such as MMP-9 and caspase 3 [PMID:40577347]
Evidence DSevere Traumatic Brain Injury (sTBI)
Evodiamine attenuated cerebral edema and reduced neuroinflammation in murine models [PMID:41242627]
Safety & adverse effects
Evodiamine has been reported to have potential toxic effects, including hepatotoxicity, nephrotoxicity, and cardiac toxicity [PMID:39345907].
Drug interactions
Pretreatment with rutaecarpine, Evodia rutaecarpa extract, or Wu-Chu-Yu-Tang significantly decreased caffeine levels in rats [PMID:16041650]. Evodol, a furanoid from the fruit, inactivates cytochrome P450 3A (CYP3A) [PMID:37092795].
Evidence summary
The evidence consists primarily of in vitro studies, animal models (D), and systematic reviews of experimental data (A/C), with limited clinical trial data (B) regarding specific formulations for nausea.
PubMed sources
1.PMID: 30616017 (2019) — Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu). · Pharmacological research
4.PMID: 37741256 (2023) — Major Indole Alkaloids in Evodia Rutaecarpa: The Latest Insights and Review of Their Impact on Gastrointestinal Diseases. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
5.PMID: 18305418 (2008) — Progress in the studies on rutaecarpine.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 39018943 (2024) — Progress on the effects and underlying mechanisms of evodiamine in digestive system diseases, and its toxicity: A systematic review and meta-analysis. · Phytomedicine : international journal of phytotherapy and phytopharmacology
7.PMID: 40577347 (2025) — Integrating network pharmacology and experimental verification to explore the protective effects of Evodia rutaecarpa in ischemic stroke. · PloS one
8.PMID: 41242627 (2025) — Evodiamine attenuates neurological impairment by inducing PANoptosis in microglia after severe traumatic brain injury. · Pharmacological research
9.PMID: 40420092 (2025) — Evodiamine induces ferroptosis in prostate cancer cells by inhibiting TRIM26-mediated stabilization of GPX4. · Chinese medicine
10.PMID: 40427497 (2025) — Rutaecarpine Protects Human Endothelial Cells from Oxidative-Stress-Induced Apoptosis via TRPV1- and AhR-Mediated Nrf2 Activation. · Antioxidants (Basel, Switzerland)
11.PMID: 38025082 (2023) — Promising derivatives of rutaecarpine with diverse pharmacological activities. · Frontiers in chemistry
12.PMID: 27771931 (2016) — Evodiamine and Its Role in Chronic Diseases. · Advances in experimental medicine and biology
13.PMID: 37787050 (2023) — Different ratios of Schisandra chinensis and Evodia rutaecarpa combination for treating Alzheimer's disease. · Experimental biology and medicine (Maywood, N.J.)
14.PMID: 12872531 (2003) — Bactericidal activity of herbal extracts. · International journal of hygiene and environmental health
15.PMID: 35379148 (2022) — Evodiamine: A Privileged Structure with Broad-ranging Biological Activities. · Mini reviews in medicinal chemistry
16.PMID: 38173117 (2024) — Therapeutic Effects of the major alkaloid constituents of Evodia rutaecarpa in Alzheimer's disease. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
17.PMID: 39798734 (2025) — Evodiamine rescues lipopolysaccharide-induced cognitive impairment via C/EBP-β-COX2 axis-regulated neuroinflammation. · International journal of biological macromolecules
18.PMID: 39345907 (2024) — Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa. · International journal of nanomedicine
19.PMID: 19471205 (2009) — Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa. · Molecules (Basel, Switzerland)
20.PMID: 35463684 (2022) — Analysis of the Molecular Mechanism of Evodia rutaecarpa Fruit in the Treatment of Nasopharyngeal Carcinoma Using Network Pharmacology and Molecular Docking. · Journal of healthcare engineering
21.PMID: 26111170 (2015) — Progress in Studies on Rutaecarpine. II.--Synthesis and Structure-Biological Activity Relationships. · Molecules (Basel, Switzerland)
22.PMID: 32774447 (2020) — Traditional Chinese medicine for anti-Alzheimer's disease: berberine and evodiamine from Evodia rutaecarpa. · Chinese medicine
23.PMID: 35366437 (2022) — Discovery of evodiamine derivatives as potent insecticide candidates. · Bioorganic & medicinal chemistry
24.PMID: 38041080 (2023) — Network pharmacology-based strategy to investigate the bioactive ingredients and molecular mechanism of Evodia rutaecarpa in colorectal cancer. · BMC complementary medicine and therapies
25.PMID: 16041650 (2005) — Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats. · Planta medica
26.PMID: 38341113 (2024) — Herbal medicine for the prevention of chemotherapy-induced nausea and vomiting in patients with advanced colorectal cancer: A prospective randomized controlled trial. · Journal of ethnopharmacology
27.PMID: 37092795 (2023) — Mechanism-based inactivation of cytochrome P450 3A by evodol. · Xenobiotica; the fate of foreign compounds in biological systems
28.PMID: 37529338 (2023) — Potential active compounds and common mechanisms of Evodia rutaecarpa for Alzheimer's disease comorbid pain by network pharmacology analysis. · Heliyon
29.PMID: 7463094 (1980) — Uterotonic effect of Evodia rutaecarpa alkaloids. · Journal of natural products
30.PMID: 37863400 (2024) — Wu-zhu-yu Decoction reduces early brain injury following subarachnoid hemorrhage in vivo and in vitro by activating the Nrf2 antioxidant system via SIRT6 targeting. · Journal of ethnopharmacology